Skip to Main Content

Paper Details

CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
Int J Cancer
14
2019
Author NameAffiliation
Brian L HoodWomens Health Integrated Research Center at Inova Health System Gynecologic Cancer Center of Excellence, Henry Jackson Foundation for the Advancement of Military Medicine
Thomas P ConradsWomens Health Integrated Research Center at Inova Health System Gynecologic Cancer Center of Excellence, Henry Jackson Foundation for the Advancement of Military Medicine
Thomas P ConradsInova Schar Cancer Institute, Inova Center for Personalized Health
  • 1 - 3

Datasets